Monsanto Co. v. Durnell — The Roundup Case at the Supreme Court Case No. 24-1068 | Argued May 2026 | Decision Expected: June/July 2026

The Background

The U.S. Supreme Court recently heard oral arguments in Monsanto Co. v. Durnell, a closely watched case that could reshape the future of Roundup litigation nationwide.

The dispute stems from a lawsuit brought by John Durnell, a Missouri resident and volunteer gardener who alleged that years of exposure to Roundup caused him to develop non-Hodgkin’s lymphoma. In 2023, a Missouri jury found in his favor and awarded him $1.25 million in damages after concluding that Monsanto failed to provide adequate warnings regarding the product’s alleged cancer risks.

Monsanto appealed, arguing that federal law governing pesticide labelling should prevent state-law failure-to-warn claims from moving forward where the U.S. Environmental Protection Agency (EPA) has not required such a warning on the product label.

Why It’s a Big Deal

At the heart of the case is a significant pre-emption question, which is: when the EPA has not required a cancer warning for Roundup, can state juries nevertheless hold Monsanto liable for failing to provide one?

Monsanto argues that allowing state-law warning claims under those circumstances would conflict with the federal regulatory framework established by the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). Durnell, on the other hand, contends that compliance with federal labelling requirements should not automatically shield a manufacturer from state-law liability.

The stakes could hardly be higher. Tens of thousands of Roundup-related lawsuits remain pending across the country, and the Supreme Court’s decision could dramatically influence their future.

Adding to the significance of the case, reports indicate that certain groups of plaintiffs have been working to finalize settlements before the Court issues its ruling. A proposed $7.25 billion settlement involving thousands of claims has drawn particular attention, as many claimants seek certainty now rather than risk an adverse Supreme Court decision later.

If the Court ultimately rules in Monsanto’s favor on pre-emption, defendants in Roundup litigation, and potentially in other product liability and mass tort cases, could gain a powerful defense against state-law failure-to-warn claims. If the Court rules for Durnell, plaintiffs may view the decision as reaffirming the ability of state juries to evaluate whether additional warnings were necessary, even when federal regulators have not mandated them.

The Supreme Court’s decision is expected by late June or July 2026 which will likely answer one of the most consequential preemption questions in mass tort history: can a federal agency’s inaction effectively immunize a company from state jury verdicts? The answer will reverberate across pharmaceutical, pesticide, and product liability litigation for years.

What’s next?   

The Supreme Court’s decision is expected by the end of the Court’s current term, likely in late June or early July 2026.

Beyond Roundup, the case is poised to address one of the most consequential questions in modern products liability litigation, as to whether a federal agency’s decision not to require a warning effectively insulate a manufacturer from state-law failure-to-warn claims.

Whatever the outcome, the ruling is expected to have implications far beyond pesticide litigation. Attorneys on both sides of the aisle are watching closely because the Court’s reasoning could influence future disputes involving pharmaceuticals, consumer products, medical devices, chemicals, and other regulated products.

For that reason, Monsanto Co. v. Durnell is not simply another Roundup case, it may become one of the defining pre-emption decisions in modern mass tort litigation.